AT-46 VORINOSTAT AND BEVACIZUMAB FOR RECURRENT HIGH-GRADE GLIOMA: INTERIM ANALYSIS OF A PHASE II CLINICAL TRIAL
Publication
, Conference
Peters, K; Reardon, D; Randazzo, D; Dutton, S; Edwards, A; Lipp, E; Herndon, J; McSherry, F; Desjardins, A; Ranjan, T; Vlahovic, G; Friedman, H
Published in: Neuro-Oncology
November 1, 2014
AT-46
Duke Scholars
Published In
Neuro-Oncology
DOI
EISSN
1523-5866
ISSN
1522-8517
Publication Date
November 1, 2014
Volume
16
Issue
suppl 5
Start / End Page
v18 / v18
Location
Miami, FL
Publisher
Oxford University Press (OUP)
Conference Name
19th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO),
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Peters, K., Reardon, D., Randazzo, D., Dutton, S., Edwards, A., Lipp, E., … Friedman, H. (2014). AT-46 VORINOSTAT AND BEVACIZUMAB FOR RECURRENT HIGH-GRADE GLIOMA: INTERIM ANALYSIS OF A PHASE II CLINICAL TRIAL. In Neuro-Oncology (Vol. 16, pp. v18–v18). Miami, FL: Oxford University Press (OUP). https://doi.org/10.1093/neuonc/nou237.45
Peters, K., D. Reardon, D. Randazzo, S. Dutton, A. Edwards, E. Lipp, J. Herndon, et al. “AT-46 VORINOSTAT AND BEVACIZUMAB FOR RECURRENT HIGH-GRADE GLIOMA: INTERIM ANALYSIS OF A PHASE II CLINICAL TRIAL.” In Neuro-Oncology, 16:v18–v18. Oxford University Press (OUP), 2014. https://doi.org/10.1093/neuonc/nou237.45.
Peters K, Reardon D, Randazzo D, Dutton S, Edwards A, Lipp E, et al. AT-46 VORINOSTAT AND BEVACIZUMAB FOR RECURRENT HIGH-GRADE GLIOMA: INTERIM ANALYSIS OF A PHASE II CLINICAL TRIAL. In: Neuro-Oncology. Oxford University Press (OUP); 2014. p. v18–v18.
Peters, K., et al. “AT-46 VORINOSTAT AND BEVACIZUMAB FOR RECURRENT HIGH-GRADE GLIOMA: INTERIM ANALYSIS OF A PHASE II CLINICAL TRIAL.” Neuro-Oncology, vol. 16, no. suppl 5, Oxford University Press (OUP), 2014, pp. v18–v18. Manual, doi:10.1093/neuonc/nou237.45.
Peters K, Reardon D, Randazzo D, Dutton S, Edwards A, Lipp E, Herndon J, McSherry F, Desjardins A, Ranjan T, Vlahovic G, Friedman H. AT-46 VORINOSTAT AND BEVACIZUMAB FOR RECURRENT HIGH-GRADE GLIOMA: INTERIM ANALYSIS OF A PHASE II CLINICAL TRIAL. Neuro-Oncology. Oxford University Press (OUP); 2014. p. v18–v18.
Published In
Neuro-Oncology
DOI
EISSN
1523-5866
ISSN
1522-8517
Publication Date
November 1, 2014
Volume
16
Issue
suppl 5
Start / End Page
v18 / v18
Location
Miami, FL
Publisher
Oxford University Press (OUP)
Conference Name
19th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO),
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences